Sundy, John S.; Baraf, Herbert S. B.; Yood, Robert A.; Edwards, N. Lawrence; Gutierrez-Urena, Sergio R.; Treadwell, Edward L.; Vazquez-Mellado, Janitzia; White, William B.; Lipsky, Peter E.; Horowitz, Zeb; Huang, William; Maroli, Allan N.; Waltrip II, Royce W.; Hamburger, Steven A.; Becker, Michael A. (2011-08-17)
Context Patients with chronic disabling gout refractory to conventional urate-lowering therapy need timely treatment to control disease manifestations related to tissue urate crystal deposition. Pegloticase, monomethoxyp ...